Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Tubular Adenocarcinoma”

684 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 684 results

Early research (Phase 1)Looking for participantsNCT06182072
What this trial is testing

ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
ProDa BioTech, LLC 46
Not applicableStudy completedNCT06947395
What this trial is testing

Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)

Who this might be right for
Cancer of the PancreasPancreatic CancerPancreas Neoplasms+2 more
Immunovia, Inc. 386
Testing effectiveness (Phase 2)Study completedNCT03410030
What this trial is testing

Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)

Who this might be right for
Pancreatic CancerPancreas CancerPancreatic Adenocarcinoma Resectable+2 more
HonorHealth Research Institute 17
Testing effectiveness (Phase 2)Looking for participantsNCT07480928
What this trial is testing

Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally Advanced or Metastatic Disease
Beijing Biotech 42
Not applicableUnknownNCT05201729
What this trial is testing

Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma, PDAC
Ruijin Hospital 30
Not applicableLooking for participantsNCT04406831
What this trial is testing

The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Stage IIIPancreatic Cancer Stage IVPancreatic Ductal Adenocarcinoma+1 more
Nuvance Health 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT06015659
What this trial is testing

ZN-c3 + Gemcitabine in Pancreatic Cancer

Who this might be right for
Advanced Pancreatic AdenocarcinomaPancreatic CancerPancreatic Ductal Adenocarcinoma
Brandon Huffman, MD 12
Not applicableUnknownNCT03840460
What this trial is testing

A Prospective Translational Tissue Collection Study in Early and Advanced Pancreatic Ductal Adenocarcinoma and Pancreatic Neuroendocrine Tumours to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers

Who this might be right for
Pancreatic Adenocarcinoma
Royal Marsden NHS Foundation Trust 200
Not applicableLooking for participantsNCT07252076
What this trial is testing

PRetreatment MRI for OCcult Liver Metastasis Assessment In Pancreatic Ductal adenocarcinoMa

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria 120
Not applicableLooking for participantsNCT07148830
What this trial is testing

Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma.

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic Cancer
Minia University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06423326
What this trial is testing

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic AdenocarcinomaStage I Pancreatic Cancer AJCC v8+2 more
Emory University 36
Not applicableStudy completedNCT05048810
What this trial is testing

Clinical Application of 68Ga-DOTA-NT-20.3 in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Nanjing First Hospital, Nanjing Medical University 6
Early research (Phase 1)Not Yet RecruitingNCT07829185
What this trial is testing

Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
University of Oklahoma 30
Early research (Phase 1)Active Not RecruitingNCT04477343
What this trial is testing

Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic Cancer
University of Rochester 20
Not applicableLooking for participantsNCT05630989
What this trial is testing

A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Mandana Kamgar, MD 80
Not applicableUnknownNCT04915417
What this trial is testing

Neoadjuvant Stereotactic Ablative Radiotherapy for Pancreatic Ductal Adenocarcinoma

Who this might be right for
Resectable Pancreatic AdenocarcinomaBorderline Resectable Pancreatic Adenocarcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 30
Testing effectiveness (Phase 2)Looking for participantsNCT07020221
What this trial is testing

VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon Small Cell Lung CancerColorectal Cancer+2 more
Verastem, Inc. 295
Testing effectiveness (Phase 2)WithdrawnNCT06592664
What this trial is testing

Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC

Who this might be right for
Pancreas CancerPancreatic CarcinomaPancreas Adenocarcinoma+5 more
Lisata Therapeutics, Inc.
Early research (Phase 1)Not Yet RecruitingNCT06981806
What this trial is testing

Phase I Study of Cosibelimab and Balixafortide in Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Arsen Osipov 24
Testing effectiveness (Phase 2)Ended earlyNCT02732938
What this trial is testing

Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Pfizer 22
Next Page